Ionis Pharmaceuticals, Inc. Financing Cash Flow
Ionis Pharmaceuticals, Inc. (IONS) reported Financing Cash Flow of -$355.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$412.29M, a 33162.87% decline year-over-year.
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $57.26M, a 2503.82% increase year-over-year.
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $591.18M.
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $81.22M, a 83.63% decline year-over-year.
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $675.84M, a 41.37% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $478.06M, a 25.78% decline from fiscal 2023.
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $644.08M.
- Ionis Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$55.30M, a 122.48% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$412.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$355.04M 10-Q · filed 2026-07-29 | $236.14M derived: sum of 3 quarters · filed 2026-07-29 | $317.36M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $57.26M 10-Q · filed 2026-04-29 | $648.43M derived: sum of 2 quarters · filed 2026-04-29 | $729.65M derived: sum of 3 quarters · filed 2026-04-29 | $730.90M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $591.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $672.39M derived: sum of 2 quarters · filed 2026-02-26 | $673.64M derived: sum of 3 quarters · filed 2026-07-29 | $675.84M 10-K · filed 2026-02-26 |
| 2025-09-30 | $81.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $82.47M derived: sum of 2 quarters · filed 2026-07-29 | $84.66M 10-Q · filed 2025-10-29 | $40.55M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $3.45M 10-Q · filed 2026-07-29 | -$40.67M derived: sum of 3 quarters · filed 2026-07-29 | $455.38M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $2.20M 10-Q · filed 2026-04-29 | -$41.92M derived: sum of 2 quarters · filed 2026-04-29 | $454.13M derived: sum of 3 quarters · filed 2026-04-29 | $456.69M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$44.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $451.93M derived: sum of 2 quarters · filed 2026-02-26 | $454.49M derived: sum of 3 quarters · filed 2026-02-26 | $478.06M 10-K · filed 2026-02-26 |
| 2024-09-30 | $496.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $498.60M derived: sum of 2 quarters · filed 2025-10-29 | $522.17M 10-Q · filed 2025-10-29 | $562.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $26.13M 10-Q · filed 2025-07-30 | $66.85M derived: sum of 3 quarters · filed 2026-02-26 | $34.58M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $23.57M 10-Q · filed 2025-04-30 | $64.29M derived: sum of 2 quarters · filed 2026-02-26 | $32.03M derived: sum of 3 quarters · filed 2026-02-26 | $175.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $40.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.46M derived: sum of 2 quarters · filed 2026-02-26 | $152.00M derived: sum of 3 quarters · filed 2026-02-26 | $644.08M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$32.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $111.27M derived: sum of 2 quarters · filed 2024-11-06 | $603.36M 10-Q · filed 2024-11-06 | $552.34M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $143.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $635.63M 10-Q · filed 2024-08-01 | $584.61M derived: sum of 3 quarters · filed 2025-02-19 | $586.44M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $492.09M 10-Q · filed 2024-05-07 | $441.07M derived: sum of 2 quarters · filed 2025-02-19 | $442.90M derived: sum of 3 quarters · filed 2025-02-19 | $444.12M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | -$51.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$49.19M derived: sum of 2 quarters · filed 2025-02-19 | -$47.97M derived: sum of 3 quarters · filed 2025-02-19 | -$55.30M 10-K · filed 2025-02-19 |
| 2022-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.05M derived: sum of 2 quarters · filed 2023-11-02 | -$4.28M 10-Q · filed 2023-11-02 | -$66.77M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$6.11M 10-Q · filed 2023-08-09 | -$68.60M derived: sum of 3 quarters · filed 2024-02-21 | -$67.14M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$7.33M 10-Q · filed 2023-05-03 | -$69.81M derived: sum of 2 quarters · filed 2024-02-21 | -$68.36M derived: sum of 3 quarters · filed 2024-02-21 | $246.19M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$62.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$61.03M derived: sum of 2 quarters · filed 2024-02-21 | $253.51M derived: sum of 3 quarters · filed 2024-02-21 | $245.93M 10-K · filed 2024-02-21 |
| 2021-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $316.00M derived: sum of 2 quarters · filed 2022-11-09 | $308.42M 10-Q · filed 2022-11-09 | -$213.06M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $314.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $306.96M 10-Q · filed 2022-08-09 | -$214.51M derived: sum of 3 quarters · filed 2023-02-22 | -$203.58M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$7.58M 10-Q · filed 2022-05-04 | -$529.06M derived: sum of 2 quarters · filed 2023-02-22 | -$518.12M derived: sum of 3 quarters · filed 2023-02-22 | -$509.69M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$521.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$510.54M derived: sum of 2 quarters · filed 2023-02-22 | -$502.11M derived: sum of 3 quarters · filed 2023-02-22 | -$596.61M 10-K · filed 2023-02-22 |
| 2020-09-30 | $10.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $19.37M derived: sum of 2 quarters · filed 2021-11-03 | -$75.13M 10-Q · filed 2021-11-03 | -$55.90M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $8.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$86.07M 10-Q · filed 2021-08-04 | -$66.84M derived: sum of 3 quarters · filed 2022-02-25 | -$80.02M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$94.50M 10-Q · filed 2021-05-05 | -$75.28M derived: sum of 2 quarters · filed 2022-02-25 | -$88.45M derived: sum of 3 quarters · filed 2022-02-25 | -$53.94M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $19.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $6.05M derived: sum of 2 quarters · filed 2022-02-25 | $40.56M derived: sum of 3 quarters · filed 2022-02-25 | $100.02M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$13.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $21.34M derived: sum of 2 quarters · filed 2020-11-04 | $80.80M 10-Q · filed 2020-11-04 | $90.44M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $34.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $93.97M 10-Q · filed 2020-08-05 | $103.62M derived: sum of 3 quarters · filed 2021-02-24 | $111.69M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $59.46M 10-Q · filed 2020-05-06 | $69.11M derived: sum of 2 quarters · filed 2021-02-24 | $77.18M derived: sum of 3 quarters · filed 2021-02-24 | $530.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $9.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $17.72M derived: sum of 2 quarters · filed 2021-02-24 | $470.64M derived: sum of 3 quarters · filed 2021-02-24 | $475.87M 10-K · filed 2021-02-24 |
| 2018-09-30 | $8.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $461.00M derived: sum of 2 quarters · filed 2019-11-06 | $466.22M 10-Q · filed 2019-11-06 | $470.48M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $452.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $458.14M 10-Q · filed 2019-08-08 | $462.40M derived: sum of 3 quarters · filed 2020-03-02 | $609.97M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $5.22M 10-Q · filed 2019-05-09 | $9.48M derived: sum of 2 quarters · filed 2020-03-02 | $157.05M derived: sum of 3 quarters · filed 2020-03-02 | $158.76M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $151.83M derived: sum of 2 quarters · filed 2020-03-02 | $153.54M derived: sum of 3 quarters · filed 2020-03-02 | $229.09M 10-K · filed 2020-03-02 |
| 2017-09-30 | $147.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $149.28M derived: sum of 2 quarters · filed 2018-11-06 | $224.83M 10-Q · filed 2018-11-06 | $231.28M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $77.26M 10-Q · filed 2018-08-07 | $83.71M derived: sum of 3 quarters · filed 2019-03-01 | $88.25M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $75.55M 10-Q · filed 2018-05-07 | $81.99M derived: sum of 2 quarters · filed 2019-03-01 | $86.54M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $10.99M derived: sum of 2 quarters · filed 2019-03-01 | $11.39M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $4.95M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $403.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $24.73M 10-K · filed 2018-02-28 | |||
| 2012-09-30 | $34.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $42.13M derived: sum of 2 quarters · filed 2012-11-06 | $40.28M 10-Q · filed 2012-11-06 | $40.87M derived: sum of 4 quarters · filed 2012-11-06 |
| 2012-06-30 | $7.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $5.88M 10-Q · filed 2012-08-06 | $6.47M derived: sum of 3 quarters · filed 2012-08-06 | $5.58M derived: sum of 4 quarters · filed 2012-11-06 |
| 2012-03-31 | -$1.85M 10-Q · filed 2012-05-09 | -$1.27M derived: sum of 2 quarters · filed 2012-05-09 | -$2.16M derived: sum of 3 quarters · filed 2012-11-06 | -$1.80M derived: sum of 4 quarters · filed 2012-11-06 |
| 2011-12-31 | $585.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$303.00K derived: sum of 2 quarters · filed 2012-11-06 | $56.00K derived: sum of 3 quarters · filed 2012-11-06 | -$672.00K 10-K · filed 2012-02-29 |
| 2011-09-30 | -$888.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$529.00K derived: sum of 2 quarters · filed 2012-11-06 | -$1.26M 10-Q · filed 2012-11-06 | $1.42M derived: sum of 4 quarters · filed 2012-11-06 |
| 2011-06-30 | $359.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$369.00K 10-Q · filed 2012-08-06 | $2.31M derived: sum of 3 quarters · filed 2012-08-06 | $1.91M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-03-31 | -$728.00K 10-Q · filed 2012-05-09 | $1.95M derived: sum of 2 quarters · filed 2012-05-09 | $1.55M derived: sum of 3 quarters · filed 2012-05-09 | $3.90M derived: sum of 4 quarters · filed 2012-05-09 |
| 2010-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $2.27M derived: sum of 2 quarters · filed 2012-02-29 | $4.63M derived: sum of 3 quarters · filed 2012-02-29 | $4.70M 10-K · filed 2012-02-29 |
| 2010-09-30 | -$401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.95M derived: sum of 2 quarters · filed 2011-11-08 | $2.02M 10-Q · filed 2011-11-08 | $4.56M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $2.42M 10-Q · filed 2011-08-08 | $4.96M derived: sum of 3 quarters · filed 2012-02-29 | $10.15M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $68.00K 10-Q · filed 2011-05-06 | $2.61M derived: sum of 2 quarters · filed 2012-02-29 | $7.79M derived: sum of 3 quarters · filed 2012-02-29 | |
| 2009-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $7.73M derived: sum of 2 quarters · filed 2012-02-29 | $202.00M 10-K · filed 2012-02-29 | |
| 2009-09-30 | $5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $199.46M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $194.27M 10-Q · filed 2010-08-09 | |||
| 2008-12-31 | $107.58M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |